beta-lapachone has been researched along with Schistosomiasis mansoni in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aires, Ade L | 1 |
| Ximenes, EC | 1 |
| Barbosa, VX | 1 |
| Góes, AJ | 1 |
| Souza, VM | 1 |
| Albuquerque, MC | 1 |
1 other study available for beta-lapachone and Schistosomiasis mansoni
| Article | Year |
|---|---|
β-Lapachone: a naphthoquinone with promising antischistosomal properties in mice.
Topics: Animals; Antiparasitic Agents; Female; Granuloma; Life Cycle Stages; Liver; Liver Diseases; Lung; Lu | 2014 |